4-(3-thienyl)-α-methylbenzylbromide | 678173-91-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(3-thienyl)-α-methylbenzylbromide
• 英文别名: 3-[4-(1-Bromoethyl)phenyl]thiophene
• CAS: 678173-91-6
• 化学式: C₁₂H₁₁BrS
• 分子量: 267.189
• InChiKey: GVALDQKHNHUSSC-UHFFFAOYSA-N

物化性质

• 沸点：
  310.4±30.0 °C(Predicted)
• 密度：
  1.399±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-(3-thienyl)-α-methylbenzylbromide 在 盐酸 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 (RS)-4-(3-thienyl)phenyl-α-methyl acetic acid
  参考文献：
  名称：

  Synthesis and evaluation of S -4-(3-thienyl)phenyl-α-methylacetic acid

  摘要：

  Herein we report an efficient procedure to synthesize S-4-(3-thienyl)phenyl-alpha-methylacetic acid, an enantiomerically pure intermediate of a recently approved nonsteroidal antiinflammatory cyclooxygenase inhibitor, atliprofen [methyl RS-4-(3-thienyl)phenyl-alpha-methylacetate]. The interactions of the active S-isomer of the acid were theoretically compared with those of S-ibuprofen through molecular docking studies using COX-1 and COX-2 protein structures. The results were corroborated by in vitro and in vivo studies. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.11.066
• 作为产物：
  描述：

  4-[(4-ethyl)phenyl]-2-chlorothiophene 在 palladium on activated charcoal N-溴代丁二酰亚胺(NBS) 、 氢气 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 74.0h， 生成 4-(3-thienyl)-α-methylbenzylbromide
  参考文献：
  名称：

  Synthesis and evaluation of S -4-(3-thienyl)phenyl-α-methylacetic acid

  摘要：

  Herein we report an efficient procedure to synthesize S-4-(3-thienyl)phenyl-alpha-methylacetic acid, an enantiomerically pure intermediate of a recently approved nonsteroidal antiinflammatory cyclooxygenase inhibitor, atliprofen [methyl RS-4-(3-thienyl)phenyl-alpha-methylacetate]. The interactions of the active S-isomer of the acid were theoretically compared with those of S-ibuprofen through molecular docking studies using COX-1 and COX-2 protein structures. The results were corroborated by in vitro and in vivo studies. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.11.066